The Sulfanilamide Crisis: A Tale of Regulation and Tragedy

This chapter explores the tumultuous relationship between a pharmaceutical company and the FDA during the Sulfanilamide disaster, emphasizing the agency's struggle to recall the dangerous drug amidst corporate resistance. It poignantly recounts the human cost of the crisis, including the loss of 105 lives, and the subsequent push for regulatory reforms in the pharmaceutical industry.